Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 3Osteoporosis 1Infertility, Female 1Coronary Disease 1Cardiovascular Diseases 1Breast Neoplasms 1Abortion, Spontaneous 1

Interventions

sofosbuvir-velpatasvir drug combination 1amlodipine, atorvastatin drug combination 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Vitamin B 6 1Vitamin B 12 1Tumor Necrosis Factor Inhibitors 1Rosuvastatin Calcium 1Progesterone 1Omeprazole 1Naproxen 1Liraglutide 1Gonadotropin-Releasing Hormone 1Geritol 1Folic Acid 1Febuxostat 1Estradiol 1Colchicine 1Cholecalciferol 1Chocolate 1Atorvastatin 1Antirheumatic Agents 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cardiovascular Diseases × Estradiol × Clear all
NCT01698164 2012-10-02

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Peking Union Medical College Hospital

Phase 4 Unknown
1,200 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Coronary Disease, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡